MycoBite 6: Masked and emerging mycotoxins

Welcome to the sixth and last episode of MycoBites. In this series, Dr. Swamy Haladi, Global Technical Commercial Manager for Selko's Mycotoxin Risk Management programme touches upon various aspects related to mycotoxin analysis. 


Wrapping up the MycoBite series on mycotoxin analysis, Dr. Swamy Haladi is highlighting the role of masked and emerging mycotoxins and how these can interfere mycotoxin diagnosis. Masked mycotoxins are hard to detect due to them being in bound form. The risk of these bound mycotoxins is that they can be released in the intestine of animals, affecting their health and performance.

Furthermore, 'emerging mycotoxins' is probably not a correct term, since these toxins have always been present, but we are now discovering new methods to analyse them. Though not commercially analysed often, they might affect the toxicity of more common mycotoxins. At Selko, we keep a close eye on developments within mycotoxin analysis, that can help us identify risks more accurately and establish effective mitigation strategies.

Interested in mycotoxin risk management? Don't miss out—stay informed and subscribe to receive alerts for upcoming MycoBite series.

MycoBite banner

Watch the other available episodes

MycoBite 1: An introduction to Mycotoxin Analysis

MycoBite 2: Is analysing mycotoxins sufficient to diagnose mycotoxicosis?

MycoBite episode 3: Taking the right sample for the right purpose

MycoBite episode 4: How many mycotoxins should you analyse?

MycoBite 5: Mycotoxin biomarker analysis: how reliable is it?

Keep yourself updated about Selko! Follow us on LinkedIn to get informed about new research findings, events, innovations and many more.

Sign up below to receive an alert when the next episode is released